Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 136(6), 1863–1873 (2009).
  Medline CASGoogle Scholar
• 2 Salama NR, Hartung ML, Mueller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11(6), 385–399 (2013).•• Broad overview of Helicobacter pylori lifestyle in the stomach and pathogenicity mechanisms.
  Medline CASGoogle Scholar
• 3 Moodley Y, Linz B, Bond RP et al. Age of the association between Helicobacter pylori and man. PLoS Pathog. 8(5), e1002693 (2012).
  Medline CASGoogle Scholar
• 4 Backert S, Clyne M, Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun. Signal. 9, 28 (2011).
  Medline CASGoogle Scholar
• 5 Gal-Mor O, Finlay BB. Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell. Microbiol. 8(11), 1707–1719 (2006).
  Medline CASGoogle Scholar
• 6 Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93(25), 14648–14653 (1996).• Describes the original discovery of the cag pathogenicity island and first functional studies.
  Medline CASGoogle Scholar
• 7 Pacchiani N, Censini S, Buti L et al. Echoes of a distant past: the cag pathogenicity island of Helicobacter pylori. Cold Spring Harb. Perspect. Med. 3(11), a010355 (2013).
  MedlineGoogle Scholar
• 8 Olbermann P, Josenhans C, Moodley Y et al. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet. 6(8), e1001069 (2010).
  MedlineGoogle Scholar
• 9 Kwok T, Zabler D, Urman S et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164), 862–866 (2007).•• First study on the identification of a host cell receptor (β1-integrin) and corresponding adhesin necessary for type IV secretion system (T4SS) function.
  Medline CASGoogle Scholar
• 10 Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278(8), 1190–1202 (2011).
  Medline CASGoogle Scholar
• 11 Fischer W. Assembly and molecular mode of action of the Helicobacter pylori cag type IV secretion apparatus. FEBS J. 278(8), 1203–1212 (2011).
  Medline CASGoogle Scholar
• 12 Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58(3), 603–610 (1990).
  Medline CASGoogle Scholar
• 13 Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA-recognition of Helicobacter 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338(8763), 332–335 (1991).
  Medline CASGoogle Scholar
• 14 Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa-immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90(12), 5791–5795 (1993).
  Medline CASGoogle Scholar
• 15 D'Elios MM, Manghetti M, De Carli M et al. T helper 1 effector cells specific for H. pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158(2), 962–967 (1997).
  MedlineGoogle Scholar
• 16 Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA-positive or CagA-negative Helicobacter pylori infection. Gut 40(3), 297–301 (1997).
  Medline CASGoogle Scholar
• 17 Alvarez-Martinez CE, Christie PJ. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73(4), 775–808 (2009).• Comprehensive overview on T4SS transporters and effectors in various bacterial pathogens.
  Medline CASGoogle Scholar
• 18 Hare S, Fischer W, Williams R et al. Identification, structure and mode of action of a new regulator of the Helicobacter pylori H. pylori 0525 ATPase. EMBO J. 26(23), 4926–4934 (2007).
  Medline CASGoogle Scholar
• 19 Cendron L, Seydel A, Angelini A et al. Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a Type IV Secretion System. J. Mol. Biol. 340(4), 881–889 (2004).
  Medline CASGoogle Scholar
• 20 Cendron L, Tasca E, Seraglio T et al. The crystal structure of CagS from the Helicobacter pylori pathogenicity island. Proteins 69(2), 440–443 (2007).
  Medline CASGoogle Scholar
• 21 Barden S, Lange S, Tegtmeyer N et al. A helical RGD motif promoting cell adhesion: crystal structures of the Helicobacter pylori type IV secretion system pilus protein CagL. Structure 21(11), 1931–1941 (2013).
  Medline CASGoogle Scholar
• 22 Cendron L, Couturier M, Angelini A et al. The Helicobacter pylori CagD (H. pylori 0545, Cag24) protein is essential for CagA translocation and maximal induction of interleukin-8 secretion. J. Mol. Biol. 386(1), 204–217 (2009).
  Medline CASGoogle Scholar
• 23 Kaplan-Türkoz B, Jiménez-Soto LF, Dian C et al. Structural insights into H. pylori oncoprotein CagA interaction with β1 integrin. Proc. Natl Acad. Sci. USA 109(36), 14640–14645 (2012).•• Presents, together with [44], the first structure of the CagA N-terminus revealing details on intramolecular and intermolecular interactions involved in CagA functions.
  MedlineGoogle Scholar
• 24 Hayashi T, Senda M, Morohashi H et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 12(1), 20–33 (2012).
  Medline CASGoogle Scholar
• 25 Pham KT, Weiss E, Jiménez Soto LF et al. CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PLoS ONE 7(4), e35341 (2012).
  Medline CASGoogle Scholar
• 26 Tanaka J, Suzuki T, Mimuro H, Sasakawa C. Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell. Microbiol. 5(6), 395–404 (2003).
  Medline CASGoogle Scholar
• 27 Barrozo RM, Cooke CL, Hansen LM et al. Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog. 9(2), e1003189 (2013).
  MedlineGoogle Scholar
• 28 Johnson EM, Gaddy JA, Voss BJ et al. Genes required for assembly of pili associated with the Helicobacter pylori cag type IV secretion system. Infect. Immun. 82(8), 3457–3470 (2014).
  MedlineGoogle Scholar
• 29 Shaffer CL, Gaddy JA, Loh JT et al. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog. 7(9), e1002237 (2011).
  Medline CASGoogle Scholar
• 30 Fischer W, Püls J, Buhrdorf R et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42(5), 1337–1348 (2001).
  Medline CASGoogle Scholar
• 31 Low HH, Gubellini F, Rivera-Calzada A et al. Structure of a type IV secretion system. Nature 508(7497), 550–553 (2014).•• Presents, together with [39], the structure of a T4SS.
  Medline CASGoogle Scholar
• 32 Kutter M, Buhrdorf R, Haas J et al. Protein subassemblies of the Helicobacter pylori Cag type IV secretion system revealed by localization and interaction studies. J. Bacteriol. 190(6), 2162–2171 (2008).• Performed a comprehensive sequence analysis of cag pathogenicity island components and yeast two-hybrid screening for potential protein–protein interactions. Immunoprecipitation studies resulted in identification of a T4SS subassembly complex at the outer membrane.
  Google Scholar
• 33 Pinto-Santini DM, Salama NR. Cag3 is a novel essential component of the Helicobacter pylori Cag type IV secretion system outer membrane subcomplex. J. Bacteriol. 191(23), 7343–7352 (2009).
  Medline CASGoogle Scholar
• 34 Andrzejewska J, Lee SK, Olbermann P et al. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J. Bacteriol. 188(16), 5865–5877 (2006).
  Medline CASGoogle Scholar
• 35 Hauck CR. Microbiology: preparing the shot. Nature 449(7164), 798–799 (2007).
  Medline CASGoogle Scholar
• 36 Bonsor DA, Weiss E, Iosub-Amir A et al. Characterization of the translocation-competent complex between the Helicobacter pylori oncogenic protein CagA and the accessory protein CagF. J. Biol. Chem. 288(46), 32897–32909 (2013).
  Medline CASGoogle Scholar
• 37 Rohde N, Püls J, Buhrdorf R et al. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. Microbiol. 49(1), 219–234 (2003).
  Medline CASGoogle Scholar
• 38 Noto JM, Gaddy JA, Lee JY et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J. Clin. Invest. 123(1), 479–492 (2013).
  Medline CASGoogle Scholar
• 39 Tan S, Noto JM, Romero-Gallo J et al. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 7(5), e1002050 (2011).• Described, together with [30], that a major target of CagA and the T4SS is the acquisition of iron from the host, playing an important role in disease development.
  Medline CASGoogle Scholar
• 40 Gaddy JA, Radin JN, Loh JT et al. The host protein calprotectin modulates the Helicobacter pylori cag type IV secretion system via zinc sequestration. PLoS Pathog. 10(10), e1004450 (2014).
  MedlineGoogle Scholar
• 41 Tegtmeyer N, Hartig R, Delahay RM et al. A small fibronectin-mimicking protein from bacteria induces cell spreading and focal adhesion formation. J. Biol. Chem. 285(30), 23515–23526 (2010).
  Medline CASGoogle Scholar
• 42 Jiménez-Soto F, Kutter S, Sewald X et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog. 5(12), e1000684 (2009).• Performed yeast two-hybrid screening and identified novel cag pathogenicity island components interacting with β1-integrin.
  MedlineGoogle Scholar
• 43 Wiedemann T, Hofbaur S, Tegtmeyer N et al. Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin-integrin linked kinase signaling complex. Gut 61(7), 986–996 (2012).
  Medline CASGoogle Scholar
• 44 Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell. Microbiol. 10(8), 1573–1581 (2008).
  Medline CASGoogle Scholar
• 45 Murata-Kamiya N, Kikuchi K, Hayashi T et al. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 7(5), 399–411 (2010).
  Medline CASGoogle Scholar
• 46 Chandran V, Fronzes R, Duquerroy S et al. Structure of the outer membrane complex of a type IV secretion system. Nature 462(7276), 1011–1015 (2009).
  Medline CASGoogle Scholar
• 47 Nešić D, Miller MC, Quinkert ZT et al. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat. Struct. Mol. Biol. 17(1), 130–132 (2010).• Reveals (together with [46]) that a CagA motif mimics substrates of a host kinase family, resembling eukaryotic protein kinase inhibitors.
  Medline CASGoogle Scholar
• 48 Saadat I, Higashi H, Obuse C et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447(7142), 330–333 (2007).
  Medline CASGoogle Scholar
• 49 Nešić D, Buti L, Lu X, Stebbins CE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc. Natl Acad. Sci. USA 111(4), 1562–1567 (2014).
  Medline CASGoogle Scholar
• 50 Franco AT, Israel DA, Washington MK et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad. Sci. USA 102(30), 10646–10651 (2005).•• Describes a highly carcinogenic H. pylori strain targeting β-catenin and inducing rapid gastric cancer development in the Mongolian gerbil model.
  Medline CASGoogle Scholar
• 51 Ohnishi N, Yuasa H, Tanaka S et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl Acad. Sci. USA 105(3), 1003–1008 (2008).•• The results provide first direct evidence for the role of CagA as a bacterial oncoprotein and the importance of CagA tyrosine phosphorylation in disease development in vivo.
  Medline CASGoogle Scholar
• 52 Glowinski F, Holland B, Thiede C et al. Analysis of T4SS-induced signaling by H. pylori using quantitative phosphoproteomics. Front. Microbiol. 5, 356 (2014).
  MedlineGoogle Scholar
• 53 Mueller D, Tegtmeyer N, Brandt S et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in western and east Asian Helicobacter pylori strains. J. Clin. Invest. 122(4), 1553–1566 (2012).
  Medline CASGoogle Scholar
• 54 Selbach M, Paul FE, Brandt S et al. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 5(4), 397–403 (2009).
  Medline CASGoogle Scholar
• 55 Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295(5555), 683–686 (2002).• Describes the first intracellular interaction partner of CagA, the phosphatase SHP-2.
  Medline CASGoogle Scholar
• 56 Tegtmeyer N, Wittelsberger R, Hartig R et al. Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori. Cell Host Microbe 9(6), 520–31 (2011).
  Medline CASGoogle Scholar
• 57 Amieva MR, Vogelmann R, Covacci A et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300(5624), 1430–1434 (2003).• Describes first evidence that CagA targets tight junctions and disrupts junction-mediated functions.
  Medline CASGoogle Scholar
• 58 Churin Y, Al-Ghoul L, Kepp O et al. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell. Biol. 161(2), 249–255 (2003).
  Medline CASGoogle Scholar
• 59 Poppe M, Feller SM, Römer G, Wessler S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26(24), 3462–3472 (2007).
  Medline CASGoogle Scholar
• 60 Tammer I, Brandt S, Hartig R et al. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132(4), 1309–1319 (2007).
  Medline CASGoogle Scholar
• 61 Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol. 18(11), 479–486 (2010).
  Medline CASGoogle Scholar
• 62 Sokolova O, Maubach G, Naumann M. MEKK3 and TAK1 synergize to activate IKK complex in Helicobacter pylori infection. Biochim. Biophys. Acta 1843(4), 715–724 (2014).
  Medline CASGoogle Scholar
• 63 Saha A, Backert S, Hammond CE et al. Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology 139(1), 239–248 (2010).
  Medline CASGoogle Scholar
• 64 Belogolov E, Bauer B, Pompaiah M et al. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell. Microbiol. 15(11), 1896–1912 (2013).
  MedlineGoogle Scholar
• 65 Viala J, Chaput C, Boneca IG et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5(11), 1166–1174 (2004).
  Medline CASGoogle Scholar